Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02628002 · ClinicalTrials.gov registry record · NA

Anti-gravity Treadmill Exercise in Stress Myocardial Perfusion Imaging

A NA study, sponsored by University of Cincinnati.

Completed
Registry status
NA
Development phase
49
Enrollment target

NCT02628002 is a NA study that has completed, run by University of Cincinnati. The registered enrollment target is 49 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02628002, a NA study, has completed, sponsored by University of Cincinnati.

COMPLETED
Registry status
NA
Development phase
49 participants
Enrollment target

Study Summary

This study will test the hypothesis that the anti-gravity treadmill can be safely used in stress nuclear myocardial perfusion imaging in patients unable to perform conventional treadmill exercise. This will be foundational evidence on which to consider a larger clinical trial to show that the anti-gravity treadmill improves diagnostic specificity across all cardiovascular stress testing modalities including treadmill-alone, exercise stress echocardiogram, exercise SPECT as well as having implications for cardiac PET and MRI in the future.

Interventions

  • DEVICE Antigravity treadmill (Alter-G)
  • DEVICE Conventional treadmill/regadenoson

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2015-12
Est. Completion 2016-09
Phase NA

Sponsor

University of Cincinnati

245 total trials

What the Registry Record Tells You About NCT02628002

The ClinicalTrials.gov registry entry for NCT02628002 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Antigravity treadmill (Alter-G) is the first listed.

NCT02628002 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02628002 about?

NCT02628002 is a clinical study titled "Anti-gravity Treadmill Exercise in Stress Myocardial Perfusion Imaging". This study will test the hypothesis that the anti-gravity treadmill can be safely used in stress nuclear myocardial perfusion imaging in patients unable to perform conventional treadmill exercise. This will be foundational evidence on which to consider a larger clinical trial to show that the anti-...

What is the current status of trial NCT02628002?

This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2015-12. Estimated completion is 2016-09.

What interventions are being tested in trial NCT02628002?

The interventions under investigation include: Antigravity treadmill (Alter-G) (DEVICE), Conventional treadmill/regadenoson (DEVICE).

Who is sponsoring clinical trial NCT02628002?

This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.